» Articles » PMID: 32987703

Spontaneous Right Ventricular Pseudoaneurysms and Increased Arrhythmogenicity in a Mouse Model of Marfan Syndrome

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Sep 29
PMID 32987703
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with Marfan syndrome (MFS), a connective tissue disorder caused by pathogenic variants in the gene encoding the extracellular matrix protein fibrillin-1, have an increased prevalence of primary cardiomyopathy, arrhythmias, and sudden cardiac death. We have performed an in-depth in vivo and ex vivo study of the cardiac phenotype of mice, an established mouse model of MFS with a severely reduced expression of fibrillin-1. Using ultrasound measurements, we confirmed the presence of aortic dilatation and observed cardiac diastolic dysfunction in male mice. Upon post-mortem examination, we discovered that the mutant mice consistently presented myocardial lesions at the level of the right ventricular free wall, which we characterized as spontaneous pseudoaneurysms. Histological investigation demonstrated a decrease in myocardial compaction in the MFS mouse model. Furthermore, continuous 24 h electrocardiographic analysis showed a decreased heart rate variability and an increased prevalence of extrasystolic arrhythmic events in mice compared to wild-type littermates. Taken together, in this paper we document a previously unreported cardiac phenotype in the MFS mouse model and provide a detailed characterization of the cardiac dysfunction and rhythm disorders which are caused by fibrillin-1 deficiency. These findings highlight the wide spectrum of cardiac manifestations of MFS, which might have implications for patient care.

Citing Articles

Abnormal Left Ventricular Strain Correlates with Left Ventricular Dysfunction but not Aortic Pathology in Marfan Syndrome in Children.

Connell P, Morris S, Doan T, Weigand J Pediatr Cardiol. 2023; 44(7):1536-1545.

PMID: 37505267 DOI: 10.1007/s00246-023-03232-8.


An Overview of Investigational and Experimental Drug Treatment Strategies for Marfan Syndrome.

Deleeuw V, De Clercq A, De Backer J, Sips P J Exp Pharmacol. 2021; 13:755-779.

PMID: 34408505 PMC: 8366784. DOI: 10.2147/JEP.S265271.


Cardiomyopathy in Genetic Aortic Diseases.

Muino-Mosquera L, De Backer J Front Pediatr. 2021; 9:682390.

PMID: 34336739 PMC: 8319542. DOI: 10.3389/fped.2021.682390.

References
1.
Kodo K, Ong S, Jahanbani F, Termglinchan V, Hirono K, InanlooRahatloo K . iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy. Nat Cell Biol. 2016; 18(10):1031-42. PMC: 5042877. DOI: 10.1038/ncb3411. View

2.
Campens L, Renard M, Trachet B, Segers P, Mosquera L, De Sutter J . Intrinsic cardiomyopathy in Marfan syndrome: results from in-vivo and ex-vivo studies of the Fbn1C1039G/+ model and longitudinal findings in humans. Pediatr Res. 2015; 78(3):256-63. DOI: 10.1038/pr.2015.110. View

3.
Taub C, Stoler J, Perez-Sanz T, Chu J, Isselbacher E, Picard M . Mitral valve prolapse in Marfan syndrome: an old topic revisited. Echocardiography. 2008; 26(4):357-64. DOI: 10.1111/j.1540-8175.2008.00825.x. View

4.
Silverman D, Burton K, Gray J, Bosner M, Kouchoukos N, Roman M . Life expectancy in the Marfan syndrome. Am J Cardiol. 1995; 75(2):157-60. DOI: 10.1016/s0002-9149(00)80066-1. View

5.
Barnabei M, Palpant N, Metzger J . Influence of genetic background on ex vivo and in vivo cardiac function in several commonly used inbred mouse strains. Physiol Genomics. 2010; 42A(2):103-13. PMC: 2957793. DOI: 10.1152/physiolgenomics.00071.2010. View